Acrivon Therapeutics, Inc. Common Stock
ACRV
$1.71-2.84%
Delayed · as of Oct 23, 2026, 2:10 PM ET
Mkt cap
$65.06M
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-0.92
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Acrivon Therapeutics, Inc. Common Stock (ACRV) is a biotechnology company listed on NASDAQ.
Use this ACRV research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ACRV income, balance, and cash tables.
Acrivon Therapeutics, Inc. Common Stock (ACRV) is a biotechnology company in the Healthcare sector.
Latest cached Acrivon Therapeutics, Inc. Common Stock (ACRV) net income for FY2025 was -$77.9M. Statements: https://lician.com/financials/acrv
Acrivon Therapeutics, Inc. Common Stock (ACRV) market capitalization is $65.1M on the latest cached snapshot.
Acrivon Therapeutics, Inc. Common Stock (ACRV) cached previous close $1.76; day range $1.68 – $1.82; volume 76,905. Session quote: https://lician.com/quote/acrv
Acrivon Therapeutics, Inc. Common Stock (ACRV) latest cached earnings event is "ACRV earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ACRV filing is 8-K · Jun 17, 2026. Filings: https://lician.com/sec/acrv